Publication | Open Access
MicroRNA-124 mediates the cholinergic anti-inflammatory action through inhibiting the production of pro-inflammatory cytokines
245
Citations
37
References
2013
Year
Inflammatory Lung DiseaseLung InflammationImmunologyImmune RegulationVagus NerveInnate ImmunityImmune SystemImmune DysregulationInflammationNeuroimmunologyCell SignalingMolecular PhysiologyAutoimmune DiseasePro-inflammatory CytokinesInflammatory ResponseChronic Inflammation'Cholinergic Anti-inflammatory PathwayImmune FunctionMicrorna DetectionPharmacologyInflammatory DiseaseCell BiologyCytokineAnti-inflammatoryImmune Cell DevelopmentSmall RnaCholinergic Anti-inflammatory ActionMedicine
The vagus nerve can control inflammatory response through a 'cholinergic anti-inflammatory pathway', which is mediated by the α7-nicotinic acetylcholine receptor (α7nAChR) on macrophages. However, the intracellular mechanisms that link α7nAChR activation and pro-inflammatory cytokine production remain not well understood. In this study, we found that miR-124 is upregulated by cholinergic agonists in LPS-exposed cells and mice. Utilizing miR-124 mimic and siRNA knockdown, we demonstrated that miR-124 is a critical mediator for the cholinergic anti-inflammatory action. Furthermore, our data indicated that miR-124 modulates LPS-induced cytokine production by targeting signal transducer and activator of transcription 3 (STAT3) to decrease IL-6 production and TNF-α converting enzyme (TACE) to reduce TNF-α release. These results also indicate that miR-124 is a potential therapeutic target for the treatment of inflammatory diseases.
| Year | Citations | |
|---|---|---|
Page 1
Page 1